Does Psyllium Cholesterol Randomized Trial work?

Updated July 2026

Quick Answer

Psyllium Cholesterol Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Hypertension and hyperlipidemia are key contributors and potential risk factors for cardiovascular disease [].

Key Takeaways

  • 01Hypertension and hyperlipidemia are key contributors and potential risk factors for cardiovascular disease []. [Gholami Zeinab (2025)]
  • 02Elevated concentrations of total cholesterol, LDL-C, and TG, along with low HDL-C levels, are associated with increased CHD risk in women [,]. [Gholami Zeinab (2025)]
  • 03Evidence suggests that both dietary soluble fiber and purified viscous soluble fiber intake are associated with lower serum cholesterol levels []. [Gholami Zeinab (2025)]
  • 041 2 3 4 5 6 7 8 9 10 11 12 13 14 16 17 18 9 11 20 1 5 23 24 25 6 Traditionally, lipid profiles were determined by analyzing blood samples after fasting for 8 to 12 h. [Gholami Zeinab (2025)]
The current Migaku evidence database contains 2 reusable source documents for Psyllium Cholesterol Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Hypertension and hyperlipidemia are key contributors and potential risk factors for cardiovascular disease []. [Gholami Zeinab (2025); evidence level 1] - Elevated concentrations of total cholesterol, LDL-C, and TG, along with low HDL-C levels, are associated with increased CHD risk in women [,]. [Gholami Zeinab (2025); evidence level 1] - Evidence suggests that both dietary soluble fiber and purified viscous soluble fiber intake are associated with lower serum cholesterol levels []. [Gholami Zeinab (2025); evidence level 1] - 1 2 3 4 5 6 7 8 9 10 11 12 13 14 16 17 18 9 11 20 1 5 23 24 25 6 Traditionally, lipid profiles were determined by analyzing blood samples after fasting for 8 to 12 h. [Gholami Zeinab (2025); evidence level 1] - In particular, it may be effective in the management of conditions such as hypertension, diabetes, and liver disease, alongside other potential health benefits, such as its ability to support gastrointestinal health, cardiovascular risk reduction, and metabolic control. [Sanlier Nevin (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Psyllium supplementation and lipid profiles: systematic review and dose-response meta-analysis of randomized controlled trials
  2. From Husks and Seeds to Health: an Inevitable Outcome Rather than a Fluke